The Latest Headlines at American Banking and Market News


Urban Outfitters (NASDAQ:URBN) Earns Market Perform Rating from Telsey Advisory Group
Urban Outfitters (NASDAQ:URBN – Get Free Report)‘s stock had its “market perform” rating reaffirmed by stock analysts at Telsey Advisory Group in a research note issued to investors on Friday,Benzinga reports.... More of this article »
Upwork (NASDAQ:UPWK) Given New $20.00 Price Target at JMP Securities
Upwork (NASDAQ:UPWK – Get Free Report) had its price target hoisted by investment analysts at JMP Securities from $18.00 to $20.00 in a research note issued on Friday,Benzinga reports. The brokerage presently has a “market... More of this article »
The Goldman Sachs Group Has Lowered Expectations for WEBTOON Entertainment (NASDAQ:WBTN) Stock Price
WEBTOON Entertainment (NASDAQ:WBTN – Free Report) had its price objective cut by The Goldman Sachs Group from $15.00 to $11.00 in a research note published on Thursday morning,Benzinga reports. They currently have a buy rating... More of this article »
Truist Financial Forecasts Strong Price Appreciation for Ulta Beauty (NASDAQ:ULTA) Stock
Ulta Beauty (NASDAQ:ULTA – Free Report) had its price target boosted by Truist Financial from $364.00 to $386.00 in a research note released on Thursday,Benzinga reports. Truist Financial currently has a neutral rating on the... More of this article »
Zoom Video Communications (NASDAQ:ZM) Given New $84.00 Price Target at Citigroup
Zoom Video Communications (NASDAQ:ZM – Free Report) had its target price lowered by Citigroup from $85.00 to $84.00 in a research report report published on Thursday,Benzinga reports. The firm currently has a neutral rating on... More of this article »
Canaccord Genuity Group Cuts Waldencast (NASDAQ:WALD) Price Target to $5.00
Waldencast (NASDAQ:WALD – Free Report) had its target price cut by Canaccord Genuity Group from $6.00 to $5.00 in a research report report published on Thursday morning,Benzinga reports. They currently have a buy rating on the... More of this article »
GeneDx (NASDAQ:WGS) Earns Buy Rating from Analysts at Guggenheim
Guggenheim initiated coverage on shares of GeneDx (NASDAQ:WGS – Free Report) in a research note issued to investors on Thursday morning, MarketBeat Ratings reports. The brokerage issued a buy rating and a $88.00 target price... More of this article »
Cantor Fitzgerald Cuts Exagen (NASDAQ:XGN) Price Target to $7.00
Exagen (NASDAQ:XGN – Free Report) had its price objective lowered by Cantor Fitzgerald from $8.00 to $7.00 in a research report released on Thursday,Benzinga reports. The brokerage currently has an overweight rating on the stock. A... More of this article »
Zscaler (NASDAQ:ZS) Stock Price Expected to Rise, Mizuho Analyst Says
Zscaler (NASDAQ:ZS – Free Report) had its price target upped by Mizuho from $220.00 to $250.00 in a research report report published on Thursday morning,Benzinga reports. They currently have a neutral rating on the stock. A number... More of this article »
Travere Therapeutics (NASDAQ:TVTX) Earns “Outperform” Rating from Wedbush
Travere Therapeutics (NASDAQ:TVTX – Get Free Report)‘s stock had its “outperform” rating reissued by equities research analysts at Wedbush in a research note issued to investors on Friday,Benzinga reports. They... More of this article »
UBS Group Lowers ZimVie (NASDAQ:ZIMV) Price Target to $10.00
ZimVie (NASDAQ:ZIMV – Free Report) had its price target trimmed by UBS Group from $16.00 to $10.00 in a report published on Thursday,Benzinga reports. The firm currently has a neutral rating on the stock. ZIMV has been the subject... More of this article »
Zentalis Pharmaceuticals (NASDAQ:ZNTL) Earns Neutral Rating from Wedbush
Wedbush restated their neutral rating on shares of Zentalis Pharmaceuticals (NASDAQ:ZNTL – Free Report) in a research note released on Thursday morning,Benzinga reports. They currently have a $4.00 price target on the stock. A... More of this article »
10x Genomics’ (TXG) “Overweight” Rating Reiterated at Stephens
Stephens reissued their overweight rating on shares of 10x Genomics (NASDAQ:TXG – Free Report) in a research note released on Thursday,Benzinga reports. Stephens currently has a $14.00 price target on the stock. Other analysts... More of this article »